Caricamento...
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration
BACKGROUND: Age‐related macular degeneration (AMD) is one of the leading causes of permanent blindness worldwide. The current mainstay of treatment for neovascular AMD (nAMD) is intravitreal injection of anti‐vascular endothelial growth factor (anti‐VEGF) agents: aflibercept, ranibizumab, and off‐la...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2020
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7202375/ https://ncbi.nlm.nih.gov/pubmed/32374423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012208.pub2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|